This inventor holds 1 USPTO granted patent. Top assignees: Irm LLC, Novartis Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 152 
1 out of 3,975 
Years Active: 2014
Title: The Innovative Contributions of Valentia Molteni in Pulmonary Hypertension Treatment
Introduction: Valentia Molteni is a notable inventor based in San Diego, California, recognized for his groundbreaking work in the field of pharmacology. His innovative approach has led to the development of significant pharmaceutical compounds aimed at treating pulmonary arterial hypertension.
Latest Patents: Valentia holds one patent titled "Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension." This patent focuses on bicyclic heterocyclic derivatives that inhibit PDGF receptor-mediated biological activity, offering potential therapeutic benefits for patients suffering from this condition.
Career Highlights: Throughout his career, Valentia has worked with prominent companies, including Irm LLC and Novartis AG. His tenure at these organizations has allowed him to contribute to important research and development projects that potentially change the landscape of pulmonary treatment options.
Collaborations: Valentia has collaborated with distinguished professionals in his field, including Ian Bruce and Sylvie Chamoin. These collaborations have fostered a productive environment for innovation and have enhanced the development of his patented solutions.
Conclusion: Valentia Molteni's work as an inventor reflects a commitment to innovation in the treatment of pulmonary arterial hypertension. His contributions, demonstrated through his patent, continue to influence the future of therapeutic advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile